These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 35040901)

  • 41. The Year in Coagulation: Selected Highlights from 2020.
    Patel PA; Henderson RA; Bolliger D; Erdoes G; Mazzeffi MA
    J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2260-2272. PubMed ID: 33781668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New antiplatelet drugs and new oral anticoagulants.
    Koenig-Oberhuber V; Filipovic M
    Br J Anaesth; 2016 Sep; 117 Suppl 2():ii74-ii84. PubMed ID: 27566810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of current antithrombotic therapy on mortality in nursing home residents with COVID-19: a multicentre retrospective cohort study.
    Boutkourt F; van Haaps T; Brüggemann R; Bhoelan S; Ten Cate H; Kruip MJHA; Spaetgens B; van Es N; Roest T; Joling KJ; Meijer K; Hugtenburg J
    Age Ageing; 2024 May; 53(5):. PubMed ID: 38748450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development.
    Ghasemiyeh P; Mohammadi-Samani S
    Virol J; 2024 Apr; 21(1):98. PubMed ID: 38671455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Composite Interventions on Outcomes of Severely and Critically Ill Patients with COVID-19 in Shanghai, China.
    Shao J; Fan R; Guo C; Huang X; Guo R; Zhang F; Hu J; Huang G; Cao L
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37513031
    [No Abstract]   [Full Text] [Related]  

  • 46. Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
    Jing H; Wu X; Xiang M; Liu L; Novakovic VA; Shi J
    Front Immunol; 2022; 13():992384. PubMed ID: 36466841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelets in COVID-19 disease: friend, foe, or both?
    Smęda M; Hosseinzadeh Maleki E; Pełesz A; Chłopicki S
    Pharmacol Rep; 2022 Dec; 74(6):1182-1197. PubMed ID: 36463349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.
    Kell DB; Pretorius E
    Biochem J; 2022 Aug; 479(16):1653-1708. PubMed ID: 36043493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?
    Ghasemzadeh M; Ahmadi J; Hosseini E
    Thromb Res; 2022 May; 213():179-194. PubMed ID: 35397313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Bradbury CA; Lawler PR; Stanworth SJ; McVerry BJ; McQuilten Z; Higgins AM; Mouncey PR; Al-Beidh F; Rowan KM; Berry LR; Lorenzi E; Zarychanski R; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Bhimani Z; Bihari S; Bonten MJM; Brunkhorst FM; Buzgau A; Buxton M; Carrier M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Huang DT; Horvat CM; Hunt BJ; Ichihara N; Lamontagne F; Leavis HL; Linstrum KM; Litton E; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Morpeth SC; Murthy S; Neal MD; Nichol AD; Parke RL; Parker JC; Reyes LF; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Singh V; Tolppa T; Turgeon AF; Turner AM; van de Veerdonk FL; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Webb SA; Gordon AC
    JAMA; 2022 Apr; 327(13):1247-1259. PubMed ID: 35315874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shining a light on platelet activation in COVID-19.
    Denorme F; Ajanel A; Campbell RA
    J Thromb Haemost; 2022 Jun; 20(6):1286-1289. PubMed ID: 35175688
    [No Abstract]   [Full Text] [Related]  

  • 52. Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era.
    Mahajan K; Batra A
    Indian Heart J; 2020; 72(3):209-211. PubMed ID: 32768026
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiplatelet Therapy in Patients With COVID-19-More Is Less?
    Spaetgens B; Nagy M; Ten Cate H
    JAMA; 2022 Jan; 327(3):223-224. PubMed ID: 35040901
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19 mortality in patients on anticoagulants and antiplatelet agents.
    Sivaloganathan H; Ladikou EE; Chevassut T
    Br J Haematol; 2020 Aug; 190(4):e192-e195. PubMed ID: 32584423
    [No Abstract]   [Full Text] [Related]  

  • 55. Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study.
    Zhou J; Lee S; Guo CL; Chang C; Liu T; Leung KSK; Wai AKC; Cheung BMY; Tse G; Zhang Q
    Pharmacol Res; 2021 Mar; 165():105473. PubMed ID: 33524539
    [No Abstract]   [Full Text] [Related]  

  • 56. Heartbeat: the role of antiplatelet therapy in treatment of COVID-19 infections.
    Otto CM
    Heart; 2022 Jan; 108(2):83-85. PubMed ID: 34937799
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.